Sone Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Sone Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$19.7M	Buy	40,158 +29,314	+270%	+$15.9M	1.66%	20
2025 Q4	$6.28M	Buy	10,844 +4,053	+60%	+$2.29M	0.51%	69
2025 Q3	$3.29M	Sell	6,791 -43,523	-87%	-$20.3M	0.28%	85
2025 Q2	$20.4M	Buy	50,314 +19,904	+65%	+$8.32M	1.88%	14
2025 Q1	$15.1M	Buy	30,410 +12,214	+67%	+$6.62M	1.56%	21
2024 Q4	$9.47M	Buy	+18,196	New	+$10M	1.2%	31

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sone Capital Management's TMO Position: Q1 2026 in Review

Sone Capital Management increased its Thermo Fisher Scientific (TMO) stake by 270% in Q1 2026, buying an estimated $15.9M and bringing the position to 40,158 shares worth $19.7M. The position accounts for 1.66% of the portfolio, ranked #20.

Sone Capital Management first reported a position in TMO in Q4 2024 and has held it in 6 quarters since. The position peaked at $20.4M in Q2 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Sone Capital Management held 40,158 shares of Thermo Fisher Scientific worth $19.7M as of Q1 2026.
Sone Capital Management bought 29,314 Thermo Fisher Scientific shares in Q1 2026, an estimated $15.9M.
Thermo Fisher Scientific made up 1.66% of Sone Capital Management's portfolio in Q1 2026, its #20 holding.
Sone Capital Management first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 6 quarters since.
Sone Capital Management's Thermo Fisher Scientific position peaked at $20.4M in Q2 2025.
2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Sone Capital Management's 13F filing for Q1 2026, filed 15 May 2026.